NCT00737191View on ClinicalTrials.gov

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Hematopoietic/Lymphoid CancerPainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

olanzapine

Given orally

OTHER

placebo

Given orally

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER